α1-Adrenergic Receptors and Their Inhibitors in Lower Urinary Tract Symptoms and Benign Prostatic Hyperplasia
Author:
Affiliation:
1. From The University of Texas Southwestern Medical Center at Dallas (CGR), Dallas, Texas, and Duke University Medical Center (DAS), Durham, North Carolina
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Urology
Reference77 articles.
1. The use of alpha-adrenergic blockers in benign prostatic obstruction;Caine;Br J Urol,1976
2. Efficacy and safety of once-daily alfuzosin in the treatment of lower urinary tract symptoms and clinical benign prostatic hyperplasia: a randomized, placebo-controlled trial;Roehrborn;Urology,2001
3. A second phase III multicenter placebo controlled study of 2 dosages of modified release tamsulosin in patients with symptoms of benign prostatic hyperplasia;Narayan;J Urol,1998
4. Terazosin, doxazosin, and prazosin: current clinical experience;Akduman;Urology,2001
5. The development of human benign prostatic hyperplasia with age;Berry;J Urol,1984
Cited by 236 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. MEDICAL EXPULSIVE THERAPY FOR UROLITHIASIS IN CHILDREN: EXPERIENCE OF USE IN FOREIGN PRACTICE. LITERATURE REVIEW.;Russian Journal of Pediatric Surgery;2024-08-07
2. A Novel ADRA1A Missence Variant (c.939G > T) in Two Related Patients with Anejaculation: Case Report;Indian Journal of Clinical Biochemistry;2024-05-28
3. Capsaicin reduces blood glucose and prevents prostate growth by regulating androgen, RAGE/IGF-1/Akt, TGF-β/Smad signalling pathway and reversing epithelial-mesenchymal transition in streptozotocin-induced diabetic mice;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-05-03
4. Alpha1-adrenergic blockers selectively antagonize the contractions induced by 6-nitrodopamine in the human vas deferens;Naunyn-Schmiedeberg's Archives of Pharmacology;2023-11-01
5. Alpha1-adrenergic antagonists act as 6-nitrodopamine receptor antagonists in the human vas deferens;2023-10-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3